Formulate Final Commercial Review Gate Decision
Synthesise the findings, risk profiles, and experiment outcomes to determine the explicit strategic path forward for the venture's commercial design. Synthesise a formal decision note selecting one clear path: Continue, Repeat, Pivot, Escalate, or Defer. Update the venture DNA and data room with the final verdict, rationale, and mandatory conditions for progression.
Completing this action enforces governance discipline by establishing an unambiguous, evidence-backed decision on commercial readiness. It prevents premature scaling on unvalidated financial models and clarifies exact next steps for the founder and stakeholders.
The founder must deliver a signed Commercial Decision Memorandum detailing the chosen pathway, explicit rationale, updated venture DNA records, and an updated data-room asset. The document must include clear conditions precedent before moving into linked operational or go-to-market execution stages.
Five questions an expert would ask when reviewing your output
Use these to challenge assumptions, pressure-test your logic, and check the quality of this action's output in the context of the parent task and wider venture development.
- 1
What definitive evidence justifies a 'Continue' decision rather than 'Repeat' or 'Pivot' given current validation gaps?
- 2
If recommending a 'Pivot' in pricing or business model, what specific empirical thresholds triggered this shift?
- 3
Under what precise conditions must this venture 'Escalate' to external commercial or legal advisors before proceeding?
- 4
How does this decision note explicitly update the investment readiness and data room asset for prospective UK investors?
- 5
What are the non-negotiable milestones that must be achieved before the venture can safely transition to the next phase?